Incidence of Right Ventricular Dysfunction in an Echocardiographic Referral Cohort

Jonah David Garry,Shi Huang,Jeffrey Annis,Suman Kundu,Anna R. Hemnes,Matthew S. Freiberg,Evan L. Brittain
DOI: https://doi.org/10.1101/2024.10.08.24315120
2024-10-09
Abstract:Introduction: Incidence rates (IRs) of RV dysfunction (RVD) are unknown. We examined the rates, risk factors, and heart failure (HF) hospitalization hazard associated with incident RVD in patients referred for Transthoracic Echocardiogram (TTE). Methods: In this retrospective cohort study, we extracted tricuspid regurgitant velocity (TRV) and tricuspid annular systolic plane excursion (TAPSE) from TTEs at Vanderbilt (2010-2023). We followed patients from their earliest TTE with normal RV function≥17mm) and a reported TRV. The primary outcome was new RVD (TAPSE<17mm), and the secondary outcome was HF hospitalization after second TTE. Poisson regression and multivariable cox models estimated IRs and hazard ratios, adjusted for demographics, comorbidities, and TTE measures. Results: Among 45,753 patients (63 years [IQR 50-72], 45% Male, 13% Black) meeting inclusion criteria, 13,735 (30.1%) underwent a follow up TTE and 4,198 (9.2%) developed RVD. The IR of RVD in the full cohort was 3.2/100 person/years (95%CI 3.1-3.3) and 8.2 (95%CI 8.0-8.5) in the repeat TTE cohort. IRs increased with rising RVSP. Risk factors for incident RVD were most prominently HF (HR 1.88; 95%CI 1.75-2.03), left-sided valvular disease (HR 1.68; 95%CI 1.53-1.85), and other cardiovascular comorbidities. Baseline RVSP >35 mmHg associated with TAPSE decline over time. Incident RVD increased hazard of HF hospitalization (HR 2.02; 95%CI 1.85-2.21). Hazard of HF hospitalization increased when TAPSE declined by ≥5mm. Conclusions: RVD incidence is substantial among patients referred for TTE. Clinical monitoring is warranted if RVSP >35mmHg. Cardiovascular comorbidities drive RVD in this population. Incident RVD associates with increased hazard of HF hospitalization.
Cardiovascular Medicine
What problem does this paper attempt to address?
The paper attempts to address the issue of the incidence of right ventricular dysfunction (RVD) and its associated clinical characteristics. Specifically: 1. **Incidence**: The study aims to report the incidence rate (IR) of RVD in patients referred for transthoracic echocardiography (TTE). Previous studies have primarily focused on the prevalence and prognostic significance of RVD in specific populations, but there is a lack of longitudinal data on the incidence of RVD. 2. **Risk Factors**: Identify clinical risk factors associated with the development of RVD to better understand the population-level drivers of RVD. 3. **Clinical Impact**: Evaluate the association between newly developed RVD and the risk of heart failure hospitalization. The study hypothesizes that cardiovascular comorbidities are the main factors associated with RVD and that newly developed RVD increases the risk of heart failure hospitalization. Through a retrospective analysis of a large number of patients, the study provides important data on the incidence of RVD and identifies cardiovascular comorbidities as major risk factors for the development of RVD. Additionally, the study finds that newly developed RVD is significantly associated with an increased risk of heart failure hospitalization. These findings help clinicians better monitor and manage patients at risk for RVD.